Cita APA (7a ed.)

Lin, J., Xu, X., Li, T., Yao, J., Yu, M., Zhu, Y., & Sun, D. (2021). OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Lin, Jiaxing, Xiao Xu, Tianren Li, Jihang Yao, Meng Yu, Yuyan Zhu, y Dan Sun. OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Lin, Jiaxing, et al. OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts. Frontiers Media S.A, 2021.